41 related articles for article (PubMed ID: 20402817)
1. Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia.
Chan CC; Chien NH; Lee CL; Yang YC; Hung CS; Tu TC; Wu CH
BMC Gastroenterol; 2015 Dec; 15():170. PubMed ID: 26635102
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Tolerability of 14-Day Tegoprazan- versus Rabeprazole-Based Triple Therapy for Eradication of
Jung YS; Kim S; Kim HY; Noh SJ; Park JH; Sohn CI; Park CH
Gut Liver; 2023 Sep; 17(5):711-721. PubMed ID: 36510776
[TBL] [Abstract][Full Text] [Related]
3. The nonadherence and risk factors of eradication failure by sequential therapy as first-line anti-Helicobacter pylori treatment in real-world clinical practice.
Lee CT; Wu CT; Chang WL; Yang EH; Hsieh MT; Chen WY; Sheu BS; Cheng HC
Helicobacter; 2024; 29(1):e13033. PubMed ID: 37950342
[TBL] [Abstract][Full Text] [Related]
4. New Diagnostic Strategies for Detection of Helicobacter pylori Infection in Pediatric Patients.
Gold BD; Gilger MA; Czinn SJ
Gastroenterol Hepatol (N Y); 2014 Dec; 10(12 Suppl 7):1-19. PubMed ID: 26491414
[TBL] [Abstract][Full Text] [Related]
5. Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infection.
Lim JH; Lee DH; Lee ST; Kim N; Park YS; Shin CM; Song IS
World J Gastroenterol; 2015 Dec; 21(46):13124-31. PubMed ID: 26673999
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication.
Hwang JJ; Lee DH; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Sep; 21(35):10234-41. PubMed ID: 26401089
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Apr; 21(16):5032-8. PubMed ID: 25945019
[TBL] [Abstract][Full Text] [Related]
8. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South Korea.
Kang KK; Lee DH; Oh DH; Yoon H; Shin CM; Park YS; Kim N; Jung HC
World J Gastroenterol; 2014 Jun; 20(22):6932-8. PubMed ID: 24944485
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of first-line triple therapy for helicobacter pylori eradication in Korea: is it time to change?
Gong EJ; Yun SC; Jung HY; Lim H; Choi KS; Ahn JY; Lee JH; Kim DH; Choi KD; Song HJ; Lee GH; Kim JH
J Korean Med Sci; 2014 May; 29(5):704-13. PubMed ID: 24851029
[TBL] [Abstract][Full Text] [Related]
11. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study.
Seddik H; Ahid S; El Adioui T; El Hamdi FZ; Hassar M; Abouqal R; Cherrah Y; Benkirane A
Eur J Clin Pharmacol; 2013 Sep; 69(9):1709-15. PubMed ID: 23695545
[TBL] [Abstract][Full Text] [Related]
12. Newer agents for Helicobacter pylori eradication.
Fiorini G; Zullo A; Gatta L; Castelli V; Ricci C; Cassol F; Vaira D
Clin Exp Gastroenterol; 2012; 5():109-12. PubMed ID: 22767998
[TBL] [Abstract][Full Text] [Related]
13. Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection.
Choi HS; Chun HJ; Park SH; Keum B; Seo YS; Kim YS; Jeen YT; Um SH; Lee HS; Kim CD; Ryu HS
World J Gastroenterol; 2012 May; 18(19):2377-82. PubMed ID: 22654429
[TBL] [Abstract][Full Text] [Related]
14. Horizontal gene transfers with or without cell fusions in all categories of the living matter.
Sinkovics JG
Adv Exp Med Biol; 2011; 714():5-89. PubMed ID: 21506007
[TBL] [Abstract][Full Text] [Related]
15. Ten-day sequential therapy as first-line treatment for Helicobacter pylori infection in Korea: a retrospective study.
Kwon JH; Lee DH; Song BJ; Lee JW; Kim JJ; Park YS; Kim N; Jeong SH; Kim JW; Lee SH; Hwang JH; Jung HC; Song IS
Helicobacter; 2010 Apr; 15(2):148-53. PubMed ID: 20402817
[TBL] [Abstract][Full Text] [Related]
16. Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study.
Oh HS; Lee DH; Seo JY; Cho YR; Kim N; Jeoung SH; Kim JW; Hwang JH; Park YS; Lee SH; Shin CM; Cho HJ; Jung HC; Song IS
J Gastroenterol Hepatol; 2012 Mar; 27(3):504-9. PubMed ID: 21916989
[TBL] [Abstract][Full Text] [Related]
17. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.
Kim YS; Kim SJ; Yoon JH; Suk KT; Kim JB; Kim DJ; Kim DY; Min HJ; Park SH; Shin WG; Kim KH; Kim HY; Baik GH
Aliment Pharmacol Ther; 2011 Nov; 34(9):1098-105. PubMed ID: 21923713
[TBL] [Abstract][Full Text] [Related]
18. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients.
Park HG; Jung MK; Jung JT; Kwon JG; Kim EY; Seo HE; Lee JH; Yang CH; Kim ES; Cho KB; Park KS; Lee SH; Kim KO; Jeon SW
Aliment Pharmacol Ther; 2012 Jan; 35(1):56-65. PubMed ID: 22066530
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of standard-dose versus half-dose rabeprazole, clarithromycin, and amoxicillin in the treatment of Helicobacter pylori infection.
Mansour NM; Hashash JG; El-Halabi M; Ghaith O; Maasri K; Sukkarieh I; Malli A; Sharara AI
Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):865-70. PubMed ID: 21811161
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
